Coccidioidomycosis Drug Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)

Coccidioidomycosis drug market is expected to grow at a significant CAGR during the forecast period (2023-2029). The fungal infection causes coccidioidomycosis, popularly known as valley fever. The fungus that causes coccidioidomycosis is called coccidioides, and it lives in soil in Mexico, the southern US, Central America, and South America. Valley fever is spread by inhaling fungus spores that are present in the air. Valley fever is characterized by fatigue, headaches, night sweats, muscle aches, and shortness of breath, among other symptoms. It is a short-term disease that has been documented to last a few days or weeks, however, some people who are affected develop symptoms that persist longer and the infection progresses to a severe form. According to the CDC, between 5 to 10% of infected people develop serious infections, necessitating effective treatment in order to live a disease-free life. Valley fever is diagnosed using a simple blood test that looks for Coccidioides antibodies or antigens, as well as a skin test to see if a person's immune response to the Coccidioides infection is working properly. Antifungal medications, such as fluconazole, are commonly used to treat coccidioidomycosis.

According to the Centers for Disease Control and Prevention (CDC), there were 18,407 cases of Valley fever reported in 2019. The majority of these occurrences occurred in the residents of Arizona and California. Valley fever is more common among persons in their 60s and older. According to data from the National Multiple Cause of Death Registry, there were roughly 200 coccidioidomycosis-related deaths per year in the US between 1999 and 2019.

The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including partnerships and collaborations, mergers and acquisitions, geographical expansion, and new product launches, to remain competitive in the marketplace. For instance, in December 2021, Sun Pharmaceutical Industries announced that the US FDA has given final approval to one of its wholly-owned subsidiaries' abbreviated new drug application (ANDA) for generic Amphotericin B Liposome for Injection, 50 mg/vial single-dose vial. The generic product approval is based on the reference product AmBisome Liposome for Injection, 50 mg/vial. Antifungal medicine amphotericin B is used to treat serious fungal infections including leishmaniasis, mucormycosis, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, and cryptococcosis.

To Request a Sample of our Report on Coccidioidomycosis Drug Market: https://www.omrglobal.com/request-sample/coccidioidomycosis-drug-market

Market Coverage

· The market number available for - 2022-2029

· Base year- 2022

· Forecast period- 2023-2029

Segment Covered-

· By Disease Type

· By End-User

Regions covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape: Johnson & Johnson Services, Inc., Pfizer Inc., and Sun Pharmaceutical Industries Ltd., among others.

Coccidioidomycosis Drug Market Report by Segment

By Disease Type

· Acute Coccidioidomycosis

· Chronic Coccidioidomycosis

· Disseminated Coccidioidomycosis.

By End-User

· Specialty clinics

· Hospitals

· Homecare

· Others

A full Report of Coccidioidomycosis Drug Market is Available @ https://www.omrglobal.com/industry-reports/coccidioidomycosis-drug-market

Coccidioidomycosis Drug Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.
https://www.asiatimeskorea.com/news/2029%eb%85%84%ea%b9%8c%ec%a7%80-%ea%b2%ac%ec%8b%a4%ed%95%9c-%ed%99%95%ec%9e%a5%ec%9d%84-%eb%aa%a9%ea%b2%a9%ed%95%98%eb%8a%94-%eb%8d%95%ed%8a%b8%eb%a6%ac%ec%8a%a4-%eb%82%9c%eb%b0%a9-%eb%b0%8f/363339/
https://monblogapple.com/2023/02/27/le-marche-des-trois-roues-electriques-generera-des-revenus-record-dici-2029/
https://www.diario-ya.com/regionales/%e5%88%b0-2029-%e5%b9%b4%ef%bc%8c%e9%a3%9f%e5%93%81%e6%8a%97%e6%b0%a7%e5%8c%96%e5%8a%91%e5%b8%82%e5%a0%b4%e5%b0%87%e5%87%ba%e7%8f%be%e9%a9%9a%e4%ba%ba%e7%9a%84%e5%a2%9e%e9%95%b7/453258/
https://revistaeconomiasocial.com/2023/02/27/el-mercado-de-medicamentos-para-el-sindrome-del-intestino-irritable-con-estrenimiento-sii-c-generara-ingresos-record-para-2029/
https://sportmsr.com/%d8%b3%d9%88%d9%82-%d9%86%d8%b8%d8%a7%d9%85-%d8%a7%d9%84%d9%81%d8%b1%d8%b2-%d9%81%d9%8a-%d8%ac%d9%85%d9%8a%d8%b9-%d8%a3%d9%86%d8%ad%d8%a7%d8%a1-%d8%a7%d9%84%d8%b9%d8%a7%d9%84%d9%85-%d8%aa%d8%ad/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: Receiver +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.